Ligand validation:2R4U

PE3: 3,6,9,12,15,18,21,24,27,30,33,36,39-TRIDECAOXAHENTETRACONTANE-1,41-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2R4U_PE3_A_504	20%	83%	0.126	0.85	0.58	0.22	-	-	0	0	30%	0.3023
2R4U_PE3_A_505	8%	85%	0.199	0.825	0.5	0.24	-	-	0	0	12%	11.63
2R4U_PE3_A_506	6%	89%	0.23	0.821	0.52	0.13	-	-	0	0	14%	13.950000000000001
2R4T_PE3_A_513	18%	82%	0.143	0.894	0.48	0.33	-	-	0	0	7%	6.98
3GUH_PE3_A_491	17%	55%	0.178	0.887	0.83	0.92	-	-	1	0	26%	0.2558
3TEO_PE3_O_207	100%	75%	0.037	0.99	0.65	0.35	-	-	2	0	93%	0.9302
6JU0_PE3_K_301	49%	98%	0.149	0.928	0.11	0.18	-	-	1	0	81%	0.814
5ODH_PE3_F_502	39%	88%	0.093	0.939	0.46	0.22	-	-	1	0	21%	0.2093
6EN5_PE3_A_726	36%	74%	0.147	0.84	0.55	0.48	-	-	2	0	100%	0.84
4BTL_PE3_A_1546	35%	52%	0.1	0.935	0.45	1.38	-	-	1	0	16%	16.28

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.